The Effect of Foam Roller Applied to the SCM Muscle on Respiratory Muscle Fatigue
Investigation of the Effect of the Foam Roller Method Applied to the Sternocleidomastoid Muscle After Respiratory Muscle Fatigue
1 other identifier
interventional
27
1 country
1
Brief Summary
The aim of this study is to examine the acute effect of the foam roller (FR) method applied to the sternocleidomastoid (SCM) muscle after respiratory muscle fatigue on joint range of motion (ROM), accessory respiratory muscle activity and muscle strength. The aim of this study is to examine the changes in fatigue and pain symptoms by applying relaxation on the tense fascia and shortened muscle as a result of resistance training, and the effect of these changes in the sternocleidomastoid (SCM) muscle on joint range of motion (ROM) and muscle strength in healthy male or female participants aged 18-30. In line with the investigators' results, it may be recommended to add foam roller (FR) to the accessory respiratory muscles in the pulmonary rehabilitation program in patients with chronic lung diseases. For this reason, the investigators think that it will provide clinical and scientific benefits. The investigators believe that it will lead studies to add foam roller (FR) to the pulmonary rehabilitation program in patients with chronic lung diseases. Participants will be informed about the risks and benefits of participating in the study and a voluntary consent form will be signed. Participants will be given a demographic data form before starting the study and will be asked to fill it out. The hypermobility value will be measured according to the Beighton score before the participants start the tests. After the inspiratory muscle training (IMT) study, foam roller (FR) will be applied to the right sternocleidomastoid (SCM) muscle. A one week washout period will be given. Afterwards, the cases will be applied foam roller (FR) to the left sternocleidomastoid (SCM) muscle after the inspiratory muscle training (IMT) study. All evaluation parameters will be repeated before and after the applications. Maximum inspiratory pressure measurement, range of motion (ROM) measurements, muscle strength tests, flexibility with a myotony measuring device, electromyography (EMG) measurements will be made before the study one by one.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 4, 2024
CompletedStudy Start
First participant enrolled
May 12, 2024
CompletedFirst Posted
Study publicly available on registry
May 13, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 17, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 17, 2024
CompletedOctober 21, 2024
October 1, 2024
5 months
May 4, 2024
October 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Muscle Stiffness and Muscle Tone of sternocleidomastoid muscle
Elasticity measurement will be evaluated with the MyotonPro brand device. Measurements will be made while the subjects are in the sitting position. Primarily, marking will be made between the adhesion site of the sternocleidomastoid (SCM) to the anterior surface of the manubrium sterni and the adhesion on the mastoid process of the temporal bone. Then the measurement will be made. The probe of the device (3 mm diameter) will be placed perpendicular to the skin surface with a constant preload (0.18 N).
1 Hour
Electromyographic activity level measurement of sternocleidomastoid muscle
Trigno Avanti brand surface electromyography (EMG) measurement sensors will be used to record the superficial EMG signals. The skin area will be cleaned with alcohol. Contraction of the sternocleidomastoid (SCM) muscle will be achieved by performing SCM neck flexion movement and electrode placement will be determined by palpating the muscle midpoint. During the initial evaluation, after the inspiratory muscle training (IMT) study and after the foam roller (FR) application, measurements will be made from both SCM muscles.
During the intervention
Secondary Outcomes (3)
Sternocleidomastoid Muscle Strength Measurements
1 Hour
Cervical joint range of motion
1 Hour
Maximum Inspiratory Pressure Measurement
1 Hour
Study Arms (2)
Foam Roller Group
EXPERIMENTALInspiratory muscle training will be done with a resistive exercise device at 80% of MIP max and for 30 breaths. After training, foam roller application will be applied to the right sternocloideomastoid muscle.
Non Foam Roller Group
EXPERIMENTALInspiratory muscle training will be done with a resistive exercise device at 80% of MIP max and for 30 breaths. Foam roller application will not be done.
Interventions
In foam roller application, a partitioned FR from the Trigger Point Grid 2.0 brand, measuring 33x14 cm and weighing 0.9 kg, with an inner part made of polyvinylchloride (PVC), will be used. Participants will roll the segmented FR with slight flexion-extension by placing the FR on the SCM muscle to apply FR from the starting point to the end point of that muscle region for the selected SCM muscle, with the person in the side stance position against the wall. This action will consist of 3 sets of 1 minute each, with a 30-second rest period between each set. It will be applied once for each region, including the right and left SCM muscle.
Inspiratory muscle training will be done with a resistive exercise device at 80% of MIP max and for 30 breaths.
Eligibility Criteria
You may qualify if:
- Healthy Adults
- Not exercising regularly for the last 6 months
- To have participated in the study voluntarily
- Individuals without widespread visceral or musculoskeletal pain were included.
You may not qualify if:
- Using pain medication
- Soft tissue, muscle and bone injury
- Spinal cord or upper extremity injuries
- Fibromyalgia
- Cases treated with myofascial release
- Individuals who did not have hypermobility according to the Beighton score were excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Health Sciences Turkey
Istanbul, 34668, Turkey (Türkiye)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof. Dr.
Study Record Dates
First Submitted
May 4, 2024
First Posted
May 13, 2024
Study Start
May 12, 2024
Primary Completion
October 17, 2024
Study Completion
October 17, 2024
Last Updated
October 21, 2024
Record last verified: 2024-10